PREGABALIN
|
148553-50-8 |
Pregabalin is indicated for management of neuropathic pain associated with diabetic peripheral neuropathy.
|
SOLIFENACIN
|
242478-37-1 |
Solifenacin is an anticholinergic and antispasmodic agent used to treat urinary
incontinence and the overactive bladder syndrome.
|
TAMSULOSIN
|
106133-20-4 |
Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
|
GEFITINIB
|
184475-35-2 |
Treatment of locally advanced or metastatic non-small cell lung cancer
|
DEFERASIROX
|
201530-41-8 |
Management of chronic Iron overload due to blood transfusion or non-transfusion
dependent THALASSEMIA.
|
RIVASTIGMINE
|
129101-54-8 |
Central nervous system and is used for the treatment of Dementia in Alzheimer disease and Parkinson disease.
|
FLUCONAZOLE
|
86386-73-4 |
Oropharyngeal candidiasis and cryptococcal meningitis in AIDS
|
PRASUGREL HYDROCHLORIDE
|
389574-19-0 |
Prevent Thrombosis in patients with acute coronary syndrome unstable angina and myocardial infraction ,
|
ESOMEPRAZOLE MAGNESIUM
|
217087-09-7 |
Esomeprazole
is used to treat certain stomach and problems: (such as acid reflux, ulcers). It works by decreasing the amount of acid your
stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. This medication helps
heal acid damage to the stomach and oesophagus, helps prevent ulcers, and may help prevent cancer of the oesophagus.
Esomeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).
|
TAPENTADOL
|
175591-09-0 |
Treatment of moderate to severe pain, and of pain associated with Diabetic Neuropathies
|
PHENYLEPHRINE HYDROCHLORIDE
|
61-76-7 |
Phenylephrine is used for the temporary relief of stuffy nose, sinus, and ear
symptoms caused by the common cold, flu, allergies, or other breathing illnesses
(e.g., sinusitis, bronchitis).
|
MODAFINIL
|
CAS NO: 68693-11-8 |
Modafinil and its R-enantiomer armodafinil are central nervous system stimulants
used to improve wakefulness in patients with excessive sleepiness. Both modafinil
and Armodafinil are associated with a low rate of serum aminotransferase
elevations during therapy, but they have not been implicated in cases of
clinically apparent acute liver injury.
|
